Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6418
    -0.0008 (-0.12%)
     
  • OIL

    83.39
    +0.66 (+0.80%)
     
  • GOLD

    2,408.10
    +10.10 (+0.42%)
     
  • Bitcoin AUD

    100,406.96
    +2,390.87 (+2.44%)
     
  • CMC Crypto 200

    1,334.09
    +21.47 (+1.57%)
     
  • AUD/EUR

    0.6024
    -0.0007 (-0.11%)
     
  • AUD/NZD

    1.0898
    +0.0024 (+0.22%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,088.16
    -306.15 (-1.76%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,967.93
    +192.55 (+0.51%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

3 Cannabis Stocks to Buy and Hold for the Next 10 Years

3 Cannabis Stocks to Buy and Hold for the Next 10 Years

It can be hard for investors to see anything good in the cannabis space through all the smoke of 2022's collapsing share prices. Thanks to the market's general malaise regarding the industry, at least three are selling at discounts and look likely to be great long-term holdings over the next decade: Trulieve Cannabis (OTC: TCNNF), NewLake Capital Partners (OTC: NLCP) and OrganiGram Holdings (NASDAQ: OGI). All three cannabis companies are trading at price-to-book ratios below what their assets would bring if sold off, and at lower ratios than other large cannabis companies such as Canopy Growth and Curaleaf Holdings.